bioAffinity Technologies BIAF Ratios (2021-2026)

NASDAQ BIAF
$5.10 +0.02 (+0.39%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

bioAffinity Technologies Quarterly Ratios

Periods 19 quarters
Latest Jun 2026

bioAffinity Technologies reported a net margin of -222.83% for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 88.82%87.30%92.54%90.55%93.75%74.97%24.78%34.61%41.29%38.73%29.24%26.21%19.92%34.84%43.49%
EBT Margin -6,742.11%-427,752.87%-71,380.39%-165,143.43%-8,793.12%-766.74%-107.12%-81.37%-87.79%-85.02%-134.40%-143.06%-317.59%-349.08%1,671.97%-268.63%-222.83%
EBIT Margin -52,382.77%-84,883.13%-69,213.17%-169,160.69%-9,009.78%-768.72%-105.83%-80.84%-87.08%-83.98%-133.47%-141.73%-198.16%-158.56%-196.94%-267.62%-220.77%
EBITDA Margin -52,382.77%-84,813.57%-68,902.77%-166,806.19%-8,903.38%-753.61%-98.32%-79.22%-85.40%-82.26%-131.53%-139.37%-194.65%-155.47%-194.59%-265.82%-219.24%
Operating Margin -52,382.77%-84,883.13%-69,213.17%-169,160.69%-9,009.78%-768.72%-105.83%-80.84%-87.08%-83.98%-133.47%-141.73%-198.16%-158.56%-196.94%-267.62%-220.77%
Net Margin -6,742.11%-427,778.96%-71,380.35%-166,426.71%-8,816.36%-767.51%-107.22%-81.53%-88.01%-85.13%-47.87%-143.53%-319.88%-349.30%1,871.11%-268.63%-222.83%
FCF Margin -28,801.00%-153,052.26%-55,440.58%-169,528.23%-6,909.57%-513.49%-72.42%-99.21%-65.09%-73.12%-75.97%-91.31%-209.58%-171.27%-160.69%-239.20%-217.87%
Efficiency
Inventory AverageInventory Avg. 0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.03M0.03M0.03M0.04M0.04M0.04M0.07M0.08M
Assets AverageAssets Avg. 13.12M11.32M9.67M9.53M9.21M8.14M7.35M6.60M6.53M6.03M5.15M8.15M11.25M9.45M7.78M
Invested CapitalInvested Cap. 0.50M0.25M0.17M0.04M1.29M1.20M1.11M1.02M0.93M0.84M0.74M0.18M0.13M0.67M0.60M0.58M
Asset Utilization RatioAsset Util. 0.000.000.030.280.610.991.421.431.461.490.830.550.600.76
Leverage & Solvency
Interest Coverage RatioInterest Cover -3.89-1.03-1.71-1.09-18.19-941.37-0.00M-134.18-116.97-82.60-93.84-91.25-117.65-169.66-5.21-427.93-531.24-245.69-120.71
Debt Ratio 0.040.020.020.000.000.000.000.000.010.010.000.000.000.00
Times Interest Earned -3.89-1.03-1.71-1.09-18.19-941.37-0.00M-134.18-116.97-82.60-93.84-91.25-117.65-169.66-5.21-427.93-531.24-245.69-120.71
Valuation
Enterprise Value -1.36M-13.50M-11.41M-9.80M-8.30M-4.51M-2.82M-2.50M-0.80M-0.80M-1.11M-0.44M-0.80M-7.70M-6.45M-3.10M-2.43M
Return Ratios
Return on SalesROS -0.67%-42.78%-7.14%-16.64%-0.88%-0.08%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%-0.03%-0.03%0.19%-0.03%-0.02%
Return on Capital EmployedROCE -33.47%-46.00%-66.74%-95.80%-114.60%-131.38%-172.48%-202.99%-261.19%-368.46%-392.96%-179.34%-126.66%-184.46%-242.71%
Return on Invested CapitalROIC -0.06%-0.06%-0.06%-0.05%-0.04%-0.03%-0.02%-0.02%-0.02%-0.02%-0.03%-0.04%-0.07%
Return on AssetsROA -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%0.02%0.02%0.02%